ADIPOQ and diabetes mellitus: Serum levels of adiponectin are markedly decreased in individuals with visceral obesity and states of insulin resistance, such as nonalcoholic fatty liver disease, atherosclerosis and type 2 diabetes mellitus, and adiponectin levels correlate inversely with insulin resistance [48].